基因页:TTN
概括?
基因ID | 7273 |
Symbol | TTN |
同义词 | cmd1g | cmh9 | cmpd4 | eomfc | hmerf | lgmd2j | mylk5 | tmd |
描述 | titin |
参考 | MIM:188840|HGNC:HGNC:12403|Ensembl:ENSG00000155657|HPRD:01787|Vega:Otthumg00000154448 |
基因type | protein-coding |
地图位置 | 2q31 |
Pascal P值 | 0.175 |
Fetal beta | -1.551 |
支持 | COMPOSITESET |
数据源中的基因
基因集名称 | 基因组方法 | 描述 | Info |
---|---|---|---|
简历:PGCNP | 全基因组协会研究 | GWAS | |
DNM:Fromer_2014 | 整个外显子组测序分析 | This study reported a WES study of 623 schizophrenia trios, reporting DNMs using genomic DNA. | |
DNM:McCarthy_2014 | 整个外显子组测序分析 | 57个三重奏的整个外显子组测序,具有零星或家族性精神分裂症。 | |
网络 | 人蛋白蛋白质相互作用网络中核心基因的最短路径距离 | Contribution to shortest path in PPI network: 0.0863 |
第一节遗传学和表观遗传学注释
DNM table
基因 | Chromosome | Position | Ref | Alt | Transcript | AA更改 | 突变类型 | Sift | CG46 | Trait | Study |
---|---|---|---|---|---|---|---|---|---|---|---|
TTN | chr2 | 179417060 | G | A | NM_003319 | P.L21124L | synonymous SNV | 精神分裂症 | DNM:McCarthy_2014 | ||
TTN | chr2 | 179638834 | C | T | NM_001256850 NM_001256850 NM_001267550 NM_001267550 NM_003319 NM_003319 NM_133378 NM_133378 NM_133379 NM_133379 NM_133432 NM_133432 NM_133437 NM_133437 |
. p.2354R>H . p.2354R>H . p.2308R>H . p.2354R>H . p.2354R>H . p.2308R>H . p.2308R>H |
splice 错过 splice 错过 splice 错过 splice 错过 splice 错过 splice 错过 splice 错过 |
精神分裂症 | DNM:Fromer_2014 |
Section II. Transcriptome annotation
基因ral gene expression (GTEx)
![无法使用](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/TTN_DE_GTEx.png)
基因expression during devlopment (BrainCloud)
脚注:
总共绘制了269个时间点,n = 38个胎儿样品(x = 1:38)。每个三角形代表一个时间点。
基因expression of temporal and spatial changes (BrainSpan)
脚注:
SC:亚皮质区域;SM:感觉运动区域;FC:额叶皮层;和TP:颞顶皮层
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
基因 | 皮尔逊的相关性 | Spearman's Correlation |
陷阱1 | 0.88 | 0.87 |
CFL1 | 0.87 | 0.88 |
PPP2R1A | 0.87 | 0.87 |
DCTN2 | 0.86 | 0.88 |
ARPC1A | 0.86 | 0.86 |
KAT5 | 0.86 | 0.85 |
PSMD3 | 0.85 | 0.84 |
CCT5 | 0.84 | 0.86 |
AKR1B1 | 0.84 | 0.85 |
NOC2L | 0.84 | 0.84 |
前10个负共表达基因 | ||
基因 | 皮尔逊的相关性 | Spearman's Correlation |
AF347015.27 | -0.76 | -0.76 |
AF347015.31 | -0.75 | -0.74 |
AF347015.8 | -0.74 | -0.73 |
AF347015.33 | -0.73 | -0.74 |
MT-CO2 | -0.73 | -0.71 |
AF347015.21 | -0.73 | -0.76 |
MT-CYB | -0.73 | -0.73 |
AF347015.2 | -0.71 | -0.71 |
AF347015.15 | -0.71 | -0.71 |
MT-ATP8 | -0.68 | -0.75 |
Section III. Gene Ontology annotation
Molecular function | 去的术语 | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0000166 | 核苷酸结合 | IEA | - | |
GO:0005089 | Rho guanyl-nucleotide exchange factor activity | IEA | - | |
去:0004601 | peroxidase activity | IEA | - | |
GO:0005516 | calmodulin binding | 塔斯 | 10481174 | |
GO:0005524 | ATP结合 | IEA | - | |
GO:0005524 | ATP结合 | 塔斯 | 9804419 | |
GO:0004674 | 蛋白质丝氨酸/苏氨酸激酶活性 | 艾达 | 9804419 | |
GO:0004674 | 蛋白质丝氨酸/苏氨酸激酶活性 | IEA | - | |
去:0004713 | protein tyrosine kinase activity | IEA | - | |
GO:0004197 | cysteine-type endopeptidase activity | IEA | - | |
GO:0016740 | transferase activity | IEA | - | |
GO:0020037 | 血红素结合 | IEA | - | |
GO:0008307 | structural constituent of muscle | 塔斯 | 7569978 | |
GO:0017022 | myosin binding | 塔斯 | 11717165 | |
GO:0042802 | 相同的蛋白质结合 | 新闻学会 | 9804419 | |
GO:0051393 | alpha-actinin binding | 塔斯 | 10481174 | |
Biological process | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0006468 | 蛋白氨基酸磷酸化 | IEA | - | |
GO:0006508 | 蛋白水解 | IEA | - | |
GO:0005975 | carbohydrate metabolic process | IEA | - | |
去:0007067 | 有丝分裂 | 塔斯 | 10481174 | |
GO:0006979 | response to oxidative stress | IEA | - | |
GO:0006941 | striated muscle contraction | 塔斯 | 7569978 | |
GO:0035023 | regulation of Rho protein signal transduction | IEA | - | |
去:0030239 | 肌原纤维组件 | 小鬼 | 9804419 | |
GO:0046777 | 蛋白氨基酸自磷酸化 | 小鬼 | 9804419 | |
细胞分量 | 去的术语 | Evidence | Neuro keywords | PubMed ID |
去:0000794 | condensed nuclear chromosome | 塔斯 | 10481174 | |
GO:0005622 | intracellular | IEA | - | |
GO:0005634 | 核 | IEA | - | |
GO:0005737 | 细胞质 | IEA | - | |
GO:0030017 | sarcomere | 塔斯 | 7569978 | |
GO:0030018 | Z disc | 艾达 | 9501083 | |
GO:0030018 | Z disc | 塔斯 | 8937992 |
第四节。蛋白质蛋白相互作用注释
Interactors | Aliases B | Official full name B | Experimental | 资源 | PubMed ID |
---|---|---|---|---|---|
ACTN1 | FLJ40884 | actinin, alpha 1 | - | HPRD,Biogrid | 11305911|11846417 |
ANK1 | ank |SPH1 |SPH2 | ankyrin 1, erythrocytic | - | HPRD,Biogrid | 12444090 |
ankrd1 | ALRP | C-193 | CARP | CVARP | MCARP | bA320F15.2 | ankyrin repeat domain 1 (cardiac muscle) | - | HPRD,Biogrid | 14583192 |
ankrd2 | ARPP | MGC104314 | Ankyrin重复域2(拉伸响应肌肉) | - | HPRD,Biogrid | 14583192 |
ankrd23 | darp |FLJ32449 |marp3 |MGC129593 | ankyrin repeat domain 23 | - | HPRD,Biogrid | 14583192 |
ASF1B | CIA-II |FLJ10604 | ASF1 anti-silencing function 1 homolog B (S. cerevisiae) | 亲和力捕获ms | BioGRID | 17353931 |
平静1 | Calml2 |CAMI |DD132 |PHKD | calmodulin 1 (phosphorylase kinase, delta) | - | HPRD | 11178895 |
CAPN3 | canp3 |canpl3 |LGMD2 |lgmd2a |MGC10767 |MGC11121 |MGC14344 |MGC4403 |NCL-1 |P94 | Calpain 3,(p94) | - | HPRD | 8537379|9642272|9185618 |9763216|10987085 |
CAPN3 | canp3 |canpl3 |LGMD2 |lgmd2a |MGC10767 |MGC11121 |MGC14344 |MGC4403 |NCL-1 |P94 | Calpain 3,(p94) | - | HPRD,Biogrid | 8537379|9642272 |
FHL2 | AAG11 | DRAL | SLIM3 | four and a half LIM domains 2 | An unspecified isoform of FHL2 (DRAL) interacts with TTN (titin). | BIND | 12432079 |
FHL2 | AAG11 | DRAL | SLIM3 | four and a half LIM domains 2 | - | HPRD,Biogrid | 12432079 |
KY | FLJ33207 | Kyphoscoliosis肽酶 | Ky与TTN的未指定同工型相互作用。这种相互作用是在小鼠ky和人类TTN之间证明的相互作用上建模的。 | BIND | 15385448 |
MYBPC3 | CMH4 | DKFZp779E1762 | FHC | MYBP-C | myosin binding protein C, cardiac | - | HPRD,Biogrid | 8631348|12202917 |
MYOM1 | MGC134946 |MGC134947 |Skelemin | myomesin 1, 185kDa | - | HPRD | 7588733 |
MYOM2 | ttnap | myomesin (M-protein) 2, 165kDa | - | HPRD | 7505783 |
MYPN | MYOP | myopalladin | 两个杂交 | BioGRID | 14583192 |
NEB | DKFZP686C1456 |FLJ11505 |FLJ36536 |FLJ39568 |FLJ39584 |NEB177D |NEM2 | 树星 | - | HPRD | 11851340|12482578 |
OBSCN | DKFZP666E245 |FLJ14124 |KIAA1556 |KIAA1639 |MGC120409 |MGC120410 |MGC120411 |MGC120412 |MGC138590 |UNC89 | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | - | HPRD,Biogrid | 11448995 |
PUF60 | fir |FLJ31379 |robpi |siahbp1 | poly-U binding splicing factor 60KDa | 亲和力捕获ms | BioGRID | 17353931 |
SQSTM1 | A170 |OSIL |PDB3 |zip3 |p60 |p62 |p62b | 隔离1 | Titin interacts with p62. This interaction was modelled on a demonstrated interaction between human Titin and rat p62. | BIND | 15802564 |
TCAP | CMD1N | LGMD2G | T-cap | TELE | telethonin | 滴定帽(雌激素) | - | HPRD,Biogrid | 9645487|9804419 |9817758|12446666 |
TCAP | CMD1N | LGMD2G | T-cap | TELE | telethonin | 滴定帽(雌激素) | Titin interacts with telethonin. This interaction was modelled on a demonstrated interaction between human Titin and telethonin from unspecified species. | BIND | 15802564 |
TRIM63 | FLJ32380 |IRF |murf1 |murf2 |RNF28 |SMRZ | tripartite motif-containing 63 | Reconstituted Complex 两个杂交 |
BioGRID | 11243782 |
TRIM63 | FLJ32380 |IRF |murf1 |murf2 |RNF28 |SMRZ | tripartite motif-containing 63 | - | HPRD | 11927605 |
V.途径注释
Pathway name | Pathway size | #szgr 2.0基因 | Info |
---|---|---|---|
KEGG HYPERTROPHIC CARDIOMYOPATHY HCM | 85 | 65 | 该途径中的所有SZGR 2.0基因 |
KEGG DILATED CARDIOMYOPATHY | 92 | 68 | 该途径中的所有SZGR 2.0基因 |
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS DN | 68 | 49 | 该途径中的所有SZGR 2.0基因 |
HOOI ST7靶向DN | 123 | 78 | 该途径中的所有SZGR 2.0基因 |
AKL HTLV1 INFECTION DN | 68 | 41 | 该途径中的所有SZGR 2.0基因 |
DARWICHE PAPILLOMA PROGRESSION RISK | 74 | 44 | 该途径中的所有SZGR 2.0基因 |
Lindgren膀胱癌簇2B | 392 | 251 | 该途径中的所有SZGR 2.0基因 |
korkola蛋黄囊肿瘤 | 62 | 33 | 该途径中的所有SZGR 2.0基因 |
Darwiche Papilloma风险高与低DN | 32 | 21 | 该途径中的所有SZGR 2.0基因 |
DAIRKEE TERT TARGETS DN | 124 | 79 | 该途径中的所有SZGR 2.0基因 |
RICKMAN HEAD AND NECK CANCER F | 54 | 32 | 该途径中的所有SZGR 2.0基因 |
SHEPARD BMYB MORPHOLINO DN | 200 | 112 | 该途径中的所有SZGR 2.0基因 |
SHEPARD BMYB TARGETS | 74 | 41 | 该途径中的所有SZGR 2.0基因 |
Shepard粉碎和燃烧突变体DN | 185 | 111 | 该途径中的所有SZGR 2.0基因 |
Chiaretti急性淋巴细胞白血病ZAP70 | 67 | 33 | 该途径中的所有SZGR 2.0基因 |
布莱洛克的老年痴呆症DISEASE INCIPIENT UP | 390 | 242 | 该途径中的所有SZGR 2.0基因 |
布莱洛克的老年痴呆症DISEASE UP | 1691年 | 1088 | 该途径中的所有SZGR 2.0基因 |
Kuninger IGF1与PDGFB的目标 | 82 | 51 | 该途径中的所有SZGR 2.0基因 |
WANG CISPLATIN RESPONSE AND XPC UP | 202 | 115 | 该途径中的所有SZGR 2.0基因 |
克拉斯的iwanaga致癌作用 | 170 | 107 | 该途径中的所有SZGR 2.0基因 |
DAIRKEE CANCER PRONE RESPONSE BPA E2 | 118 | 65 | 该途径中的所有SZGR 2.0基因 |
ACEVEDO LIVER CANCER WITH H3K27ME3 UP | 295 | 149 | 该途径中的所有SZGR 2.0基因 |
Yauch刺猬信号传导旁分泌DN | 264 | 159 | 该途径中的所有SZGR 2.0基因 |
Rutella对CSF2RB和IL4的响应 | 338 | 225 | 该途径中的所有SZGR 2.0基因 |
RUTELLA RESPONSE TO HGF DN | 235 | 144 | 该途径中的所有SZGR 2.0基因 |
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN | 245 | 150 | 该途径中的所有SZGR 2.0基因 |
GUTIERREZ CHRONIC LYMPHOCYTIC LEUKEMIA DN | 56 | 39 | 该途径中的所有SZGR 2.0基因 |
BRUINS UVC RESPONSE VIA TP53 GROUP A | 898 | 516 | 该途径中的所有SZGR 2.0基因 |
BRUINS UVC RESPONSE LATE | 1137 | 655 | 该途径中的所有SZGR 2.0基因 |
BRUINS UVC RESPONSE EARLY LATE | 317 | 190 | 该途径中的所有SZGR 2.0基因 |
Section VI. microRNA annotation
miRNA family | 目标位置 | mirna id | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-101 | 205 | 211 | 1A | HSA-MIR-101 | UACAGUACUGUGAUAACUGAAG |
mir-144 | 204 | 211 | 1A,m8 | hsa-miR-144 | uacaguauagauguauguaguag |
mir-17-5p/20/93.mr/106/519.D | 530 | 536 | 1A | HSA-MIR-17-5P | CAAAGUGCUUACAGUGCAGGUAGU |
HSA-MIR-20A脑 | uaaagugcuuauagugcagguag | ||||
HSA-MIR-106A | aaaagugcuuacugugcagguagc | ||||
HSA-MIR-106BSZ | uaaagugcugacagugcagau | ||||
HSA-MIR-20BSZ | caaagugcuugugcagguag | ||||
hsa-miR-519d | CAAAGUGCCUCCCUUUAGAGUGU | ||||
miR-208 | 538 | 544 | m8 | HSA-MIR-208 | AUAAGACGAGCAAAAAGCUUGU |
mir-24 | 830 | 836 | 1A | HSA-MIR-24SZ | UGGCUCAGUUCAGCAGGAACAG |
miR-433-3p | 574 | 580 | m8 | HSA-MIR-433脑 | AUCAUGAUGGGCUCCUCGGUGU |
miR-451 | 224 | 231 | 1A,m8 | HSA-MIR-451脑 | aaaccguuaccauuacugugaguuu |
mir-493-5p | 198 | 204 | m8 | hsa-miR-493-5p | UUGUACAUGGUAGGCUUUCAUU |
mir-542-3p | 560 | 566 | 1A | HSA-MIR-542-3P | ugugacauugauaacugaaa |